State-of-the art cancer screening systems for over 17 lakh women

Chennai, October 03 2018:TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized domain intensive services provider in Life Sciences, today announced its support for Preventive Oncology with Cancer Institute (WIA) in Chennai as part of its CSR initiative. This project is particularly important as this aligns with TAKE’s core expertise in Oncology and is fitting that it is being initiated in the Breast Cancer Awareness Month. Navitas Life Sciences, a TAKE Solutions Enterprise has supported over 650 oncology studies with some of the largest players in the therapeutic area.

Cervical cancer and breast cancer are the most common cause of cancer deaths among women in India, but early detection and proper treatment can improve this prognosis and can make cancer curable. A study conducted by E&Y and FICCI has reported that in India, 2,000 women are newly diagnosed with cancer every day. 1,200 of these cases are detected in late stages, which reduces the 5-year survival rate by 3 to 17 times for breast and cervical cancer. This late detection also raises the cost of treatment by 1.5 to 2 times that for early-stage cancers.

The major thrust in cancer control is early detection and prevention. Towards this, the Cancer Institute has a functional preventive oncology department set- up for early detection screening, education centres in Villupuram, Gummidipoondi, Pudukkottai and Thiruvannamaalai and a Cancer Exhibition and mammomobile for breast cancer screening. The department also functions as the training centre to train staff and coordinate the activities at the different centres. Through their efforts, the Cancer Institute has covered nearly 2,18,000 households across 260 villages in Tamil Nadu and enabled early detection screening for over 90,820 women and men.

Srinivasan H R, Vice Chairman and Managing Director, TAKE Solutions Limited, said, “As part of our CSR initiative, we are delighted to support the Cancer Institute’s (WIA) Preventive Oncology unit, functioning in and around Chennai. Through its work, the department raises awareness in early detection, education and screening of the rural population in villages around Chennai. As a Life Sciences organization, TAKE’s business has an impact on human health. This initiative is particularly important to our organisation since Oncology is one of our primary therapeutic areas of focus.”

About the Cancer Institute

The Cancer Institute (WIA), established in 1954 under the Societies' Registration Act of 1860, is an autonomous non-profit Charitable Comprehensive Cancer Centre comprising of a hospital of 550 beds, a Research Centre, Dr.Muthulakshmi College of Oncologic Sciences, and a division of Preventive Oncology. Of the hospital beds, only 40% are paying beds and the remaining are general beds and patients admitted to these beds are provided food, accommodation, routine investigations, radiotherapy and surgery free of cost. 30% are treated totally free and the remaining pay a nominal amount. The Institute is recognized by the Government of India as a "Regional Centre of Cancer Treatment and Research" for the Southern Region. The hospital sees over 120,000 cancer patients, new and old, annually. They are drawn from all over the country, South and South East Asia but mainly from the Southern States of Tamil Nadu, Andhra Pradesh, Pondicherry, Karnataka and Kerala.

About TAKE Solutions

TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management.

In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Our range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Our global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.

In Supply Chain Management, TAKE focuses on high-margin niches in engineering services, and supply chain collaboration. Our IP-led approach enables its clients to automate supply chain processes, track, trace & control at item level, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes.

With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange. Led by a team of industry stalwarts and domain experts, TAKE has been growing steadily with FY18 revenues touching INR 15,872 Mn, (USD 246 Mn).

For more information, please visit

Media information::
Rajeswari Pradeep Kumar, TAKE Solutions, +91 44 66110700, This email address is being protected from spambots. You need JavaScript enabled to view it.


Registered Office

No. 27, Tank Bund Road,
Chennai - 600034, India

Email :

Phone : +91 44 6611 0700/701

©2022 TAKE Solutions Limited